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Material and Methods: A bespoke QA programme was 
created for the 5 anatomical treatment sites which included 
spine and nodal metastasis. Prior to treatment centres were 
required to complete a QA process which included planning 
benchmark cases. Participating centres were provided with a 
pre-outlined planning CT. They created PTV expansions using 
local protocols. The centres were then required to create a 
plan based on a 30 Gy in 3 fraction prescription for the nodal 
case and a 24 Gy in 3 fractions prescription for the spine 
case. Both cases required a D95% of the prescription dose for 
the PTV coverage whilst ensuring OAR tolerances were met. 
All planning benchmarks were submitted and centrally 
analysed using VODCA 5.4 plan review software. The 
coverage of the PTV and CTV with the prescription dose, 
doses to OARs and measures of conformity were calculated. 
The values for the different submissions were compared to 
ensure plans were of suitable quality and comparable across 
different treatment platforms.  
 
Results: A total of 10 and 11 plans were submitted for the 
spine and nodal benchmark cases respectively, including all 4 
NHS cyberknife centres and the remainder using VMAT. 27% 
of the nodal and 18% of the spine plans had unacceptable 
deviations and the centres were given feedback and asked to 
resubmit their QA. The PTV coverage and max dose were 
compared for the different treatment techniques with the 
standard deviation. These can be seen in the table below. 
 
 
 
A 2 tail Mann-Whitney test was performed on the PTV 
coverage data for both plans. This indicated that there was a 
significant difference between cyberknife and VMAT plans 
(p=0.02).  
 
Conclusion: Cyberknife plans on average achieved superior 
PTV coverage when compared to VMAT plans. This was more 
evident for the spine PTV and nodal PTV 1, with both volumes 
being close to OARs, than for the nodal PTV 2 where OARs did 
not restrict the dose . The VMAT plans involved larger PTV 
and PRV expansions which would partly explain the difficulty 
in achieving the required PTV coverage. However, several of 
the VMAT plans had similar PTV coverage to the cyberknife 
plans, hence the greater variation in PTV coverage of the 
VMAT plans may reflect possible inexperience in SABR 
planning for some centres. Following resubmissions, all 
centres participating in the CtE programme have been able to 
produce acceptable benchmark plans regardless of treatment 
platform.  
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Purpose or Objective: Preclinical studies are critical steps in 
the medical research process, normally requiring dedicated 
instruments. For those centers in which both preclinical 
research and clinical practices are conducted, the dosimetric 
feasibility of small animal irradiation with clinical devices 
may be of economical and scientific interest. The aim of the 
present work is to investigate the feasibility of small animal 
irradiation with Tomotherapy Hi-Art by analyzing dosimetric 
results, toxicity and tumour response in xenograft models. 
 
Material and Methods: Xenograft models were established by 
injecting human derived glioblastoma multiforme stem-like 
cells in immunocompromised NOD-SCID mice both 
subcutaneously (10 groups) and intracranially (7 groups). Mice 
of each group were anesthetized and placed in a plexiglas 
cage pie to perform CT scans for treatment planning 
purposes. Target volumes and organs at risk (OARs) where 
outlined on CT scans: for subcutaneous xenografts, target 
volumes were delineated on the right flank and contoured 
OARs were lung and gastro-intestinal tract. For orthotopic 
models, a ring-shaped target structure was delineated on 
mice’s head; contoured OAR was lung. Three fractionation 
schedules were tested: 4Gy/1 fraction, 4 Gy/2 fractions and 
6 Gy/3 fractions. TomoDirect IMRT technique was applied, 
with gantry fixed at 0° and 180. 5 subcutaneous and 1 
orthotopic groups of xenografts were irradiated by covering 
the target volume with a 0.6 cm bolus layer in order to 
reduce the impact of the build-up effect. Irradiations 
originally performed without bolus were simulated with a 0.6 
cm virtual bolus in order to compare dosimetric results. 
Before irradiation, a MVCT image has been acquired to 
correct irradiation setup. Mice were observed daily and 
sacrificed when they showed signs of suffering or when 
tumour volume reached the established endpoint. Different 
radiobiological outcomes were evaluated, regarding both 
radiotoxicity (survival experiments) and tumour response 
(assessed by caliper or bioluminescence imaging), comparing 
irradiated mice as respect to their controls. 
 
Results: Dosimetric results showed that the presence of the 
bolus layer significantly impact the maximum dose received 
by both target volumes and OARs (t-test, p<0.05). Survival 
analysis showed that irradiation with a dose of 6 Gy in 3 
fractions in the presence of a bolus layer prolong mice 
survival (Log-rank test, p<0.02), showing to be the safest 
irradiation protocol. Tumour volume response and mice 
survival were significantly different in irradiated xenografts 
as compared to their controls (t-test, p<0.03; Log-rank, 
p<0.05) demonstrating also the radiobiological potential of 
Tomotherapy in inducing tumour growth stabilization. 
 
Conclusion: Tomotherapy systems may be a useful mean for 
small animal irradiation.  
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Purpose or Objective: To evaluate the dosimetric properties 
of acrylonitrile butadiene styrene (ABS) and polylactide (PLA) 
plastics, and their suitability for bolus printing applied in 
high-energy radiotherapy to overcome the skin-sparing 
effect. 
 
Material and Methods: The measurements were performed 
with Vero® System (Brainlab AG, Feldkirchen, Germany) 
delivering 200 monitor units (dose rate of 500 MU/min) with a 
6 MV photon beam, 5x5 cm open field with 90-degree gantry 
angle at 100 cm surface to surface distance (SSD) on a water-
equivalent RW3 slab phantom in three configurations: 
without bolus, with a commercial bolus and with the eight 3D 
